3,798
Views
0
CrossRef citations to date
0
Altmetric
Original Article

Measuring the impact of gastrointestinal inconvenience and symptoms on perceived health in the general population – validation of the Short Health Scale for gastrointestinal symptoms (SHS-GI)

, , , , &
Pages 1406-1413 | Received 24 May 2021, Accepted 24 Aug 2021, Published online: 14 Sep 2021

References

  • Del’arco A, Magalhaes P, Quilici FA. Sim brasil Study – Women's gastrointestinal health: gastrointestinal symptoms and impact on the Brazilian women quality of life. Arq Gastroenterol. 2017;54(2):115–122.
  • Clevers E, Tornblom H, Simren M, et al. Relations between food intake, psychological distress, and gastrointestinal symptoms: a diary study. United Eur Gastroenterol J. 2019;7(7):965–973.
  • Whitehead WE, Crowell MD, Robinson JC, et al. Effects of stressful life events on bowel symptoms: subjects with irritable bowel syndrome compared with subjects without bowel dysfunction. Gut. 1992;33(6):825–830.
  • Walter SA, Kjellstrom L, Nyhlin H, et al. Assessment of normal bowel habits in the general adult population: the popcol study. Scand J Gastroenterol. 2010;45(5):556–566.
  • Palsson OS, Whitehead W, Tornblom H, et al. Prevalence of Rome IV functional bowel disorders among adults in the United States, Canada, and the United Kingdom. Gastroenterology. 2020;158(5):1262–1273 e3.
  • Sperber AD, Bangdiwala SI, Drossman DA, et al. Worldwide prevalence and burden of functional gastrointestinal disorders, results of Rome foundation global study. Gastroenterology. 2021;160(1):99–114.e3.
  • Hahn BA, Yan SK, Strassels S. Impact of irritable bowel syndrome on quality of life and resource use in the United States and United Kingdom. Digestion. 1999;60(1):77–81.
  • Gralnek IM, Hays RD, Kilbourne A, et al. The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology. 2000;119(3):654–660.
  • Simren M, Abrahamsson H, Svedlund J, et al. Quality of life in patients with irritable bowel syndrome seen in referral centers versus primary care: the impact of gender and predominant bowel pattern. Scand J Gastroenterol. 2001;36(5):545–552.
  • Motzer SA, Hertig V, Jarrett M, et al. Sense of coherence and quality of life in women with and without irritable bowel syndrome. Nurs Res. 2003;52:329–337.
  • Bray BD, Nicol F, Penman ID, et al. Symptom interpretation and quality of life in patients with irritable bowel syndrome. Br J Gen Pract. 2006;56(523):122–126.
  • Simren M, Svedlund J, Posserud I, et al. Health-related quality of life in patients attending a gastroenterology outpatient clinic: functional disorders versus organic diseases. Clin Gastroenterol Hepatol. 2006;4(2):187–195.
  • Faresjo A, Anastasiou F, Lionis C, et al. Health-related quality of life of irritable bowel syndrome patients in different cultural settings. Health Qual Life Outcomes. 2006;4(1):21.
  • Koloski NA, Boyce PM, Jones MP, et al. What level of IBS symptoms drives impairment in health-related quality of life in community subjects with irritable bowel syndrome? Are current IBS symptom thresholds clinically meaningful? Quality of life research: an international journal of quality of life aspects of treatment. Qual Life Res. 2012;21(5):829–836.
  • Naliboff BD, Kim SE, Bolus R, et al. Gastrointestinal and psychological mediators of health-related quality of life in IBS and IBD: a structural equation modeling analysis. Am J Gastroenterol. 2012;107(3):451–459.
  • Varni JW, Shulman RJ, Self MM, et al. Gastrointestinal symptoms predictors of health-related quality of life in patients with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2016;63(6):e186–e192.
  • Hjortswang H, Strom M, Almer S. Health-related quality of life in Swedish patients with ulcerative colitis. Am J Gastroenterol. 1998;93(11):2203–2211.
  • Hjortswang H, Tysk C, Bohr J, et al. Health-related quality of life is impaired in active collagenous colitis. Dig Liver Dis. 2011;43(2):102–109.
  • Stjernman H, Tysk C, Almer S, et al. Unfavourable outcome for women in a study of health-related quality of life, social factors and work disability in Crohn's disease. Eur J Gastroenterol Hepatol. 2011;23:671–679.
  • Glia A, Lindberg G. Quality of life in patients with different types of functional constipation. Scand J Gastroenterol. 1997;32(11):1083–1089.
  • Sun SX, Dibonaventura M, Purayidathil FW, et al. Impact of chronic constipation on health-related quality of life, work productivity, and healthcare resource use: an analysis of the national health and wellness survey. Dig Dis Sci. 2011;56(9):2688–2695.
  • Wald A, Sigurdsson L. Quality of life in children and adults with constipation. Best Pract Res Clin Gastroenterol. 2011;25(1):19–27.
  • Talley NJ, Weaver AL, Zinsmeister AR. Impact of functional dyspepsia on quality of life. Digest Dis Sci. 1995;40(3):584–589.
  • Talley NJ. Quality of life in functional dyspepsia. Scand J Gastroenterol Suppl. 1996;221:21–22.
  • Talley NJ, Verlinden M, Jones M. Quality of life in functional dyspepsia: responsiveness of the nepean dyspepsia index and development of a new 10-item short form. Aliment Pharmacol Ther. 2001;15(2):207–216.
  • Rothbarth J, Bemelman WA, Meijerink WJ, et al. What is the impact of fecal incontinence on quality of life? Dis Colon Rectum. 2001;44(1):67–71.
  • Bartlett L, Nowak M, Ho YH. Impact of fecal incontinence on quality of life. WJG. 2009;15(26):3276–3282.
  • Walter S, Hjortswang H, Holmgren K, et al. Association between bowel symptoms, symptom severity, and quality of life in Swedish patients with fecal incontinence. Scand J Gastroenterol. 2011;46(1):6–12.
  • Alsheik EH, Coyne T, Hawes SK, et al. Fecal incontinence: prevalence, severity, and quality of life data from an outpatient gastroenterology practice. Gastroenterol Res Pract. 2012;2012:1–7.
  • Rajindrajith S, Devanarayana NM, Benninga MA. Fecal incontinence in adolescents is associated with child abuse, somatization, and poor health-related quality of life. J Pediatr Gastroenterol Nutr. 2016;62(5):698–703.
  • Mundet L, Ribas Y, Arco S, et al. Quality of life differences in female and male patients with fecal incontinence. J Neurogastroenterol Motil. 2015;22(1):94–101.
  • Brochard C, Chambaz M, Ropert A, et al. Quality of life in 1870 patients with constipation and/or fecal incontinence: constipation should not be underestimated. Clin Res Hepatol Gastroenterol. 2019;43(6):682–687.
  • Mayer EA. Gut feelings: the emerging biology of gut-brain communication. Nat Rev Neurosci. 2011;12(8):453–466.
  • Vandvik PO, Kristensen P, Aabakken L, et al. Abdominal complaints in general practice. Scand J Prim Health Care. 2004;22(3):157–162.
  • Sandler RS, Stewart WF, Liberman JN, et al. Abdominal pain, bloating, and diarrhea in the United States: prevalence and impact. Dig Dis Sci. 2000;45(6):1166–1171.
  • Tielemans MM, Jaspers Focks J, van Rossum LG, et al. Gastrointestinal symptoms are still prevalent and negatively impact health-related quality of life: a large cross-sectional population based study in The Netherlands. PLoS One. 2013;8(7):e69876.
  • van Kerkhoven LA, Eikendal T, Laheij RJ, et al. Gastrointestinal symptoms are still common in a general Western population. Neth J Med. 2008;66:18–22.
  • Von Korff M, Dworkin SF, Le Resche L, et al. An epidemiologic comparison of pain complaints. Pain. 1988;32(2):173–183.
  • Kroenke K, Price RK. Symptoms in the community. Prevalence, classification, and psychiatric comorbidity. Arch Intern Med. 1993;153(21):2474–2480.
  • Rief W, Hessel A, Braehler E. Somatization symptoms and hypochondriacal features in the general population. Psychosom Med. 2001;63(4):595–602.
  • Lee AD, Spiegel BM, Hays RD, et al. Gastrointestinal symptom severity in irritable bowel syndrome, inflammatory bowel disease and the general population. Neurogastroenterol Motil. 2017;29(5):e13003.
  • Hellers G. A new quality of life questionnaire for patients with inflammatory bowel disease. Cleve Clin J Med. 1992;59(1):56–57.
  • Vergara M, Casellas F, Badia X, et al. Assessing the quality of life of household members of patients with inflammatory bowel disease: development and validation of a specific questionnaire. Am J Gastroenterol. 2002;97(6):1429–1437.
  • Alcala MJ, Casellas F, Fontanet G, et al. Shortened questionnaire on quality of life for inflammatory bowel disease. Inflamm Bowel Dis. 2004;10:383–391.
  • Casellas F, Alcala MJ, Prieto L, et al. Assessment of the influence of disease activity on the quality of life of patients with inflammatory bowel disease using a short questionnaire. Am J Gastroenterol. 2004;99(3):457–461.
  • Wiklund IK, Fullerton S, Hawkey CJ, et al. An irritable bowel syndrome-specific symptom questionnaire: development and validation. Scand J Gastroenterol. 2003;38(9):947–954.
  • Krarup AL, Peterson E, Ringstrom G, et al. The short health scale: a simple, valid, reliable, and responsive way of measuring subjective health in patients with irritable bowel syndrome. J Clin Gastroenterol. 2015;49(7):565–570.
  • Hjortswang H, Jarnerot G, Curman B, et al. The short health scale: a valid measure of subjective health in ulcerative colitis. Scand J Gastroenterol. 2006;41(10):1196–1203.
  • Stjernman H, Granno C, Jarnerot G, et al. Short health scale: a valid, reliable, and responsive instrument for subjective health assessment in Crohn's disease. Inflamm Bowel Dis. 2008;14:47–52.
  • Bodger K, Ormerod C, Shackcloth D, et al. Development and validation of a rapid, generic measure of disease control from the patient's perspective: the IBD-control questionnaire. Gut. 2014;63(7):1092–1102.
  • Hjortswang H, Strom M, Almeida RT, et al. Evaluation of the RFIPC, a disease-specific health-related quality of life questionnaire, in Swedish patients with ulcerative colitis. Scand J Gastroenterol. 1997;32(12):1235–1240.
  • Dupuy H. The psychological general Well-Being (PGWB) index. In: Wenger NK, Mattson ME, Furberg CF, Elinson J, editors. Assessment of quality of life in clinical trials of cardiovascular therapies. Darien (CT): Le Jacq Publishing Inc.; 1984. p. 170–183.
  • McDermott E, Keegan D, Byrne K, et al. The short health scale: a valid and reliable measure of health related quality of life in English speaking inflammatory bowel disease patients. J Crohns Colitis. 2013;7(8):616–621.
  • Coenen S, Weyts E, Geens P, et al. Short health scale: a valid and reliable measure of quality of life in dutch speaking patients with inflammatory bowel disease. Scand J Gastroenterol. 2019;54(5):592–596.
  • Park SK, Ko BM, Goong HJ, et al. Short health scale: a valid measure of health-related quality of life in Korean-speaking patients with inflammatory bowel disease. World J Gastroenterol. 2017;23(19):3530–3537.
  • Jelsness-Jorgensen LP, Bernklev T, Moum B. Quality of life in patients with inflammatory bowel disease: translation, validity, reliability and sensitivity to change of the Norwegian version of the short health scale (SHS). Qual Life Res. 2012;21(9):1671–1676.
  • Abdovic S, Pavic AM, Milosevic M, et al. Short health scale: a valid, reliable, and responsive measure of health-related quality of life in children with inflammatory bowel disease. Inflamm Bowel Dis. 2015;21(4):818–823.
  • Zhu D, Zhou Y, Xu H. Reliability and validity of the Chinese version of the short health scale for inflammatory bowel diseases. Chin Nurs Manage. 2018;18:1630–1634.
  • Kjellstrom L, Molinder H, Agreus L, et al. A randomly selected population sample undergoing colonoscopy: prevalence of the irritable bowel syndrome and the impact of selection factors. Eur J Gastroenterol Hepatol. 2014;26(3):268–275.
  • Ragnarsson G, Bodemar G. Division of the irritable bowel syndrome into subgroups on the basis of daily recorded symptoms in two outpatients samples. Scand J Gastroenterol. 1999;34(10):993–1000.
  • Lewis SJ, Heaton KW. Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol. 1997;32(9):920–924.
  • Drossman DA. ROME II. The functional gastrointestinal disorders. Diagnosis, pathophysiology and treatment: a multinational concencus. 2nd ed. McLean (VA): Degnon Associates; 2000.
  • Schermelleh-Engel K, Kerwer M, Klein AG. Evaluation of model fit in nonlinear multilevel structural equation modeling. Front Psychol. 2014;5:181.
  • Wilson S, Roberts L, Roalfe A, et al. Prevalence of irritable bowel syndrome: a community survey. Br J Gen Pract. 2004;54(504):495–502.
  • Wigington WC, Johnson WD, Minocha A. Epidemiology of irritable bowel syndrome among African Americans as compared with whites: a population-based study. Clin Gastroenterol Hepatol. 2005;3(7):647–653.
  • Vandvik PO, Lydersen S, Farup PG. Prevalence, comorbidity and impact of irritable bowel syndrome in Norway. Scand J Gastroenterol. 2006;41(6):650–656.
  • Boyce PM, Talley NJ, Burke C, et al. Epidemiology of the functional gastrointestinal disorders diagnosed according to Rome II criteria: an Australian population-based study. Intern Med J. 2006;36(1):28–36.
  • Bjelland I, Dahl AA, Haug TT, et al. The validity of the hospital anxiety and depression scale. An updated literature review. J Psychosom Res. 2002;52(2):69–77.
  • Haug TT, Mykletun A, Dahl AA. Are anxiety and depression related to gastrointestinal symptoms in the general population? Scand J Gastroenterol. 2002;37(3):294–298.
  • Brenes GA. Anxiety, depression, and quality of life in primary care patients. Prim Care Companion J Clin Psychiatry. 2007;9(6):437–443.
  • Crawford JR, Henry JD, Crombie C, et al. Normative data for the HADS from a large non-clinical sample. Br J Clin Psychol. 2001;40(4):429–434.
  • Bharucha AE, Zinsmeister AR, Locke GR, et al. Prevalence and burden of fecal incontinence: a population-based study in women. Gastroenterology. 2005;129(1):42–49.
  • Karling P, Abrahamsson H, Dolk A, et al. Function and dysfunction of the Colon and anorectum in adults: working team report of the Swedish motility group (SMoG). Scand J Gastroenterol. 2009;44(6):646–660.
  • Whitehead WE, Borrud L, Goode PS, et al. Fecal incontinence in US adults: epidemiology and risk factors. Gastroenterology. 2009;137(2):512–7. 517 e1–2.
  • Miner PB. Jr. Economic and personal impact of fecal and urinary incontinence. Gastroenterology. 2004;126(1):S8–S13.
  • Bharucha AE, Zinsmeister AR, Locke GR, et al. Symptoms and quality of life in community women with fecal incontinence. Clin Gastroenterol Hepatol. 2006;4(8):1004–1009.
  • Meyer I, Richter HE. Impact of fecal incontinence and its treatment on quality of life in women. Womens Health. 2015;11(2):225–238.
  • Hjortswang H, Jarnerot G, Curman B, et al. Validation of the inflammatory bowel disease questionnaire in Swedish patients with ulcerative colitis. Scand J Gastroenterol. 2001;36(1):77–85.